**3. Conclusion**

Reducing the cost of immunosuppression can help to make renal transplantation financially viable to low cost economies without state funded insurance schemes. As this could lead to increased risk of graft rejection, these strategies may need to be restricted to those committed for regular follow up and drug compliance with low immunological risk.

## **Acknowledgements**

The assistance of residents and staff in the department of Nephrology, Government Medical College, Thiruvananthapuram in preparing this manuscript is gratefully acknowledged.

### **Funding Statement**

This study has not received any funding from any source.
